As malignancies such as pancreatic and breast cancer interfere with cDC1 development (9, 11), this alternative T cell priming may be more detrimental than beneficial and underscores an essential role for cDC1s in adaptive immunity to carcinomas. This evidence concerns the gene MPPE1 and breast carcinoma.